DEDICA (Dose of HEparin During Coronary Angioplasty) Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1000 participants.
Also called NCT01694459
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,000 participants
- Registry
-
NCT01694459
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT01694459. Randomized; single masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2012-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- DEDICA (Dose of HEparin During Coronary Angioplasty) Trial
- Acronym
- DEDICA
- Condition
- Stable Angina
- Condition
- Angina, Unstable
- Condition
- Non-ST Elevation (NSTEMI) Myocardial Infarction
- Intervention (Drug)
- Low-dose heparin
- Intervention (Drug)
- Standard dose heparin
- Lead sponsor
- San Filippo Neri General Hospital
- Collaborator
- University of Roma La Sapienza
Record details
- Record id
cardio:ct-nct01694459- Content hash
7c52f0b6bbef32ff1d8e6c86ba0eb4a717fe17cfcbe47f0918b42c0e37e602d8